Includes technologies from the cell and gene therapy space, including NK cells, stem cells, T cells, AAV, Adenovirus, CRISPR, DNA, Lentivirus, RNA and vaccinia.
University of Pittsburgh researchers have developed a novel set of quality control standards for selecting human corneal stromal stem cells (CSSCs) with optimal regenerative capabilities.